ATC Group: D01AC10 Bifonazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01AC10 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01A Antifungals for topical use
4 D01AC Imidazole and triazole derivatives
5 D01AC10 Bifonazole

Active ingredients in D01AC10

Active Ingredient Description
Bifonazole

Bifonazole is an imidazole derivative with a broad antimycotic spectrum, which includes dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur. It is also effective against Corynebacterium minutissimum.

Related product monographs

Title Information Source Document Type  
CANESPOR Cream Health Products Regulatory Authority (IE) MPI, EU: SmPC
CANESTEN BIFONAZOLE ONCE DAILY Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Mexico (MX)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.